Swanberg_2002_Drug.Saf_25_511

Reference

Title : Benefit-risk considerations in the treatment of dementia with Lewy bodies - Swanberg_2002_Drug.Saf_25_511
Author(s) : Swanberg MM , Cummings JL
Ref : Drug Safety , 25 :511 , 2002
Abstract : Swanberg_2002_Drug.Saf_25_511
ESTHER : Swanberg_2002_Drug.Saf_25_511
PubMedSearch : Swanberg_2002_Drug.Saf_25_511
PubMedID: 12093309

Related information

Citations formats

Swanberg MM, Cummings JL (2002)
Benefit-risk considerations in the treatment of dementia with Lewy bodies
Drug Safety 25 :511

Swanberg MM, Cummings JL (2002)
Drug Safety 25 :511